Apr 11, 2022

Eric Adams is the CEO and President of InMed Pharmaceuticals, exploring the benefits of rare cannabinoids from the cannabis plant. We have these naturally occurring cannabinoids in our body and a number of receptors throughout our body that respond to this class of compounds. Because these rare cannabinoids exist in low...

Apr 11, 2022

Eric Adams is the CEO and President of InMed Pharmaceuticals, exploring the benefits of rare cannabinoids from the cannabis plant. We have these naturally occurring cannabinoids in our body and a number of receptors throughout our body that respond to this class of compounds. Because these rare cannabinoids exist in low...

Oct 25, 2021

Dr. Daniel Schneeberger is the CEO of Anebulo Pharmaceuticals and is determined to find an antidote to acute cannabinoid intoxication, a growing problem for people of all ages as well as emergency rooms around the country.

Daniel says, "THC acts mostly in the brain, it crosses the blood-brain barrier and binds to the...

Oct 25, 2021

Dr. Daniel Schneeberger is the CEO of Anebulo Pharmaceuticals and is determined to find an antidote to acute cannabinoid intoxication, a growing problem for people of all ages as well as emergency rooms around the country.

Daniel says, "THC acts mostly in the brain, it crosses the blood-brain barrier and binds to the...

Jul 28, 2021

Dr. Pier Vincenzo Piazza is Co-Founder and CEO of Aelis Farma, a biotechnology company targeting disorders induced by external cannabinoids, the chemical compounds contained in cannabis.  These cannabis-related disorders include addiction, cannabinoid hyperemesis syndrome, and psychosis and are related to how the CB1...